华润医药(03320)附属华润双鹤获准发行总额为30亿元的公司债券

Core Viewpoint - China Resources Pharmaceutical (03320) announced that its non-wholly owned subsidiary, China Resources Double Crane Pharmaceutical Co., Ltd. (Double Crane), has received a registration approval notice from the China Securities Regulatory Commission for the issuance of corporate bonds to qualified investors in the People's Republic of China [1] Group 1 - The approval notice (Zheng Jian Xu Ke [2026] No. 118) is valid for 24 months from the date of issuance [1] - Within this validity period, Double Crane is allowed to issue corporate bonds totaling RMB 3 billion [1]